Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Novartis Pharmaceuticals.
Real, source-linked trial activity for Novartis Pharmaceuticals: 15 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Aug 5, 2026. Source-linked, daily-refreshed.
N/A 9PHASE3 2PHASE2 2PHASE4 1PHASE1 1
Newest Novartis Pharmaceuticals trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 2d ago | A Study of Treatment Patterns and Annualized Relapse Rate in Multiple | N/A | COMPLETED | ↗ |
| 5d ago | Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk P | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 6d ago | A Real-World Medical Chart Review of Spinal Muscular Atrophy Patients | N/A | NOT_YET_RECRUITING | ↗ |
| 6d ago | A Study to Assess the Safety of Subcutaneous Secukinumab for Treatment | N/A | NOT_YET_RECRUITING | ↗ |
| 6d ago | A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 15d ago | A Study to Characterize the Clinical Presentation and Course of Crypto | N/A | RECRUITING | ↗ |
| 16d ago | Study to Assess Safety and Clinical Responses With Coartem® Baby Dispe | Ph 4 | NOT_YET_RECRUITING | ↗ |
| 23d ago | Pluvicto Real-world Investigation in Survival in Metastatic CRPC | N/A | NOT_YET_RECRUITING | ↗ |
| 28d ago | A Study of Early Secukinumab Treatment in Moderate to Severe Hidradeni | N/A | NOT_YET_RECRUITING | ↗ |
| 34d ago | A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability o | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 36d ago | A Study of Real-World Characteristics, Treatment Patterns, and Clinica | N/A | NOT_YET_RECRUITING | ↗ |
| 36d ago | A Study of Real-World Characteristics, Treatment Patterns, and Outcome | N/A | NOT_YET_RECRUITING | ↗ |
| 42d ago | An Extension Study to Assess Safety and Efficacy of Remibrutinib in Pa | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 44d ago | Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid T | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 49d ago | A Study of Peptide Receptor Radionuclide Therapy (PRRT) Use in Neuroen | N/A | COMPLETED | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Novartis Pharmaceuticals (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.